Bevtas 400 mg

Brand: Bevtas 400 mg
Composition: Bevacizumab
Company: Intas
Form : Injection
Packing:  1 vail  in 1 box
Share :

Related Products

Bevtas 400mg is a prescription medication used to treat certain types of cancer, including:
  • Metastatic breast cancer (in combination with chemotherapy)
  • Metastatic non-small cell lung cancer (NSCLC)
  • Metastatic renal cell carcinoma (RCC)
  • Metastatic cervical cancer
  • Metastatic ovarian cancer
  • Metastatic glioblastoma
Composition: Bevtas 400mg is a single-ingredient product containing Bevacizumab, a humanized monoclonal antibody that targets the vascular endothelial growth factor (VEGF) protein. Mechanism of Action: Bevacizumab works by inhibiting the activity of VEGF, which is a key factor in the development of new blood vessels that supply tumors with oxygen and nutrients. By inhibiting VEGF, Bevacizumab reduces the growth of new blood vessels and slows down the progression of cancer. Uses: Bevtas 400mg is used to treat various types of cancer, including:
  • Metastatic breast cancer (in combination with chemotherapy)
  • Metastatic NSCLC
  • Metastatic RCC
  • Metastatic cervical cancer
  • Metastatic ovarian cancer
  • Metastatic glioblastoma
Dosage: The recommended dosage of Bevtas 400mg is:
  • 400mg administered as an intravenous infusion every 2 weeks
  • Continue treatment until disease progression or unacceptable toxicity
Side Effects: Common side effects of Bevtas 400mg include:
  • Fatigue
  • Headache
  • High blood pressure
  • Nausea
  • Vomiting
  • Diarrhea
  • Increased risk of bleeding
  • Decreased platelet count
  • Decreased white blood cell count
  • Increased risk of heart failure
  • Hypertension
Recommendation: Bevtas 400mg is recommended for patients with advanced cancer who have not responded to previous treatments. Patients should also be advised to monitor their blood counts and liver function regularly during treatment. Important Note: Patients should not take Bevtas 400mg if they have a history of severe allergic reactions, heart problems, or kidney problems. Patients should also inform their healthcare provider if they have any underlying medical conditions, such as hypertension or thyroid problems, before taking Bevtas 400mg. Please note that Bevtas 400mg is not available in all markets and may be approved for different indications and dosages in different regions.

Bevtas 400mg is a prescription medication used to treat certain types of cancer, including:

  • Metastatic breast cancer (in combination with chemotherapy)
  • Metastatic non-small cell lung cancer (NSCLC)
  • Metastatic renal cell carcinoma (RCC)
  • Metastatic cervical cancer
  • Metastatic ovarian cancer
  • Metastatic glioblastoma

Composition:

Bevtas 400mg is a single-ingredient product containing Bevacizumab, a humanized monoclonal antibody that targets the vascular endothelial growth factor (VEGF) protein.

Mechanism of Action:

Bevacizumab works by inhibiting the activity of VEGF, which is a key factor in the development of new blood vessels that supply tumors with oxygen and nutrients. By inhibiting VEGF, Bevacizumab reduces the growth of new blood vessels and slows down the progression of cancer.

Uses:

Bevtas 400mg is used to treat various types of cancer, including:

  • Metastatic breast cancer (in combination with chemotherapy)
  • Metastatic NSCLC
  • Metastatic RCC
  • Metastatic cervical cancer
  • Metastatic ovarian cancer
  • Metastatic glioblastoma

Dosage:

The recommended dosage of Bevtas 400mg is:

  • 400mg administered as an intravenous infusion every 2 weeks
  • Continue treatment until disease progression or unacceptable toxicity

Side Effects:

Common side effects of Bevtas 400mg include:

  • Fatigue
  • Headache
  • High blood pressure
  • Nausea
  • Vomiting
  • Diarrhea
  • Increased risk of bleeding
  • Decreased platelet count
  • Decreased white blood cell count
  • Increased risk of heart failure
  • Hypertension

Recommendation:

Bevtas 400mg is recommended for patients with advanced cancer who have not responded to previous treatments. Patients should also be advised to monitor their blood counts and liver function regularly during treatment.

Important Note:

Patients should not take Bevtas 400mg if they have a history of severe allergic reactions, heart problems, or kidney problems. Patients should also inform their healthcare provider if they have any underlying medical conditions, such as hypertension or thyroid problems, before taking Bevtas 400mg.

Please note that Bevtas 400mg is not available in all markets and may be approved for different indications and dosages in different regions.

We offer a variety of shipping options, including Express Mail Service (EMS), USPS, DHL, FedEx, TNT, UPS, Aramex, Air Cargo, and sea freight.

Terms and Conditions – 

Bulk Orders: You are responsible for any local import duties and taxes in your country.

For Patients: When ordering prescription medicines for personal use, or for a friend or relative, a valid medical practitioner’s script or prescription is required.

Return and Refund Policy: Due to the nature of our products, we cannot accept returns or exchanges once a purchase is made. However, in the event of non-delivery, you are eligible for either a 100% refund or a reshipment of your order.

Bevtas 400mg is a prescription medication used to treat certain types of cancer, including:

  • Metastatic breast cancer (in combination with chemotherapy)
  • Metastatic non-small cell lung cancer (NSCLC)
  • Metastatic renal cell carcinoma (RCC)
  • Metastatic cervical cancer
  • Metastatic ovarian cancer
  • Metastatic glioblastoma

Composition:

Bevtas 400mg is a single-ingredient product containing Bevacizumab, a humanized monoclonal antibody that targets the vascular endothelial growth factor (VEGF) protein.

Mechanism of Action:

Bevacizumab works by inhibiting the activity of VEGF, which is a key factor in the development of new blood vessels that supply tumors with oxygen and nutrients. By inhibiting VEGF, Bevacizumab reduces the growth of new blood vessels and slows down the progression of cancer.

Uses:

Bevtas 400mg is used to treat various types of cancer, including:

  • Metastatic breast cancer (in combination with chemotherapy)
  • Metastatic NSCLC
  • Metastatic RCC
  • Metastatic cervical cancer
  • Metastatic ovarian cancer
  • Metastatic glioblastoma

Dosage:

The recommended dosage of Bevtas 400mg is:

  • 400mg administered as an intravenous infusion every 2 weeks
  • Continue treatment until disease progression or unacceptable toxicity

Side Effects:

Common side effects of Bevtas 400mg include:

  • Fatigue
  • Headache
  • High blood pressure
  • Nausea
  • Vomiting
  • Diarrhea
  • Increased risk of bleeding
  • Decreased platelet count
  • Decreased white blood cell count
  • Increased risk of heart failure
  • Hypertension

Recommendation:

Bevtas 400mg is recommended for patients with advanced cancer who have not responded to previous treatments. Patients should also be advised to monitor their blood counts and liver function regularly during treatment.

Important Note:

Patients should not take Bevtas 400mg if they have a history of severe allergic reactions, heart problems, or kidney problems. Patients should also inform their healthcare provider if they have any underlying medical conditions, such as hypertension or thyroid problems, before taking Bevtas 400mg.

Please note that Bevtas 400mg is not available in all markets and may be approved for different indications and dosages in different regions.

Reviews

There are no reviews yet.

Be the first to review “Bevtas 400 mg”

Your email address will not be published. Required fields are marked *

Bevtas 400mg is a prescription medication used to treat certain types of cancer, including:

  • Metastatic breast cancer (in combination with chemotherapy)
  • Metastatic non-small cell lung cancer (NSCLC)
  • Metastatic renal cell carcinoma (RCC)
  • Metastatic cervical cancer
  • Metastatic ovarian cancer
  • Metastatic glioblastoma

Composition:

Bevtas 400mg is a single-ingredient product containing Bevacizumab, a humanized monoclonal antibody that targets the vascular endothelial growth factor (VEGF) protein.

Mechanism of Action:

Bevacizumab works by inhibiting the activity of VEGF, which is a key factor in the development of new blood vessels that supply tumors with oxygen and nutrients. By inhibiting VEGF, Bevacizumab reduces the growth of new blood vessels and slows down the progression of cancer.

Uses:

Bevtas 400mg is used to treat various types of cancer, including:

  • Metastatic breast cancer (in combination with chemotherapy)
  • Metastatic NSCLC
  • Metastatic RCC
  • Metastatic cervical cancer
  • Metastatic ovarian cancer
  • Metastatic glioblastoma

Dosage:

The recommended dosage of Bevtas 400mg is:

  • 400mg administered as an intravenous infusion every 2 weeks
  • Continue treatment until disease progression or unacceptable toxicity

Side Effects:

Common side effects of Bevtas 400mg include:

  • Fatigue
  • Headache
  • High blood pressure
  • Nausea
  • Vomiting
  • Diarrhea
  • Increased risk of bleeding
  • Decreased platelet count
  • Decreased white blood cell count
  • Increased risk of heart failure
  • Hypertension

Recommendation:

Bevtas 400mg is recommended for patients with advanced cancer who have not responded to previous treatments. Patients should also be advised to monitor their blood counts and liver function regularly during treatment.

Important Note:

Patients should not take Bevtas 400mg if they have a history of severe allergic reactions, heart problems, or kidney problems. Patients should also inform their healthcare provider if they have any underlying medical conditions, such as hypertension or thyroid problems, before taking Bevtas 400mg.

Please note that Bevtas 400mg is not available in all markets and may be approved for different indications and dosages in different regions.

Reviews

There are no reviews yet.

Be the first to review “Bevtas 400 mg”

Your email address will not be published. Required fields are marked *

Medical Disclaimer

Anteka Pharmacy primary intention is to ensure that its consumers get information that is reviewed by experts, accurate and trustworthy. The information and contents of this website are for informational purposes only. They are not intended to be a substitute for professional medical advice, diagnosis, or treatment. Please seek the advice of your doctor and discuss all your queries related to any disease or medicine. Do not disregard professional medical advice or delay in seeking it because of something you have read on Anteka Pharmacy. Our mission is to support, not replace, the doctor-patient relationship.
Scroll to Top

Log in

Create an Account

Send Enquiry For Bevtas 400 mg